Codexis (CDXS) Announces Dosing of First Subjects in Phase 1a Trial of CDX-6114

July 9, 2018 8:08 AM

Codexis, Inc. (NASDAQ: CDXS) announces that it has dosed the first subjects in a first-in-human Phase 1a dose-escalation trial with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found